In vitro - In vivo evaluation of a novel drug delivery system for colonic targeting

Farmacia

Volumn 58, Issue 3, 2010, Pages 368-377

  Tomuta, I ^a   Vlase, L ^a   Popa, Adina ^a   Leucuta, S E ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Colonic delivery; Indomethacin; Minitablets; Time and pH dependent delivery

Indexed keywords

CITRIC ACID TRIETHYL ESTER; EUDRAGIT; EUDRAGIT RS; INDOMETACIN; LACTOSE; MAGNESIUM STEARATE; MICROCRYSTALLINE CELLULOSE; PIGMENT; POVIDONE; SILICON DIOXIDE; STARCH GLYCOLATE SODIUM; TALC; TITANIUM DIOXIDE;

ARTICLE; BLOOD LEVEL; CLINICAL EVALUATION; CLINICAL TRIAL; COLON; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; OUTCOME ASSESSMENT; PH; RANDOMIZED CONTROLLED TRIAL; TABLET COMPRESSION; TABLET DISINTEGRATION TIME; TABLET FRIABILITY; TABLET HARDNESS;

EID: 77953882982     PISSN: 00148237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Leopold C.S., Eikeler D., Basic coating polymer for the colon-specific drug delivery in inflammatory bowel disease, Drug Dev. Ind. Pharm, 2000, 26(12), 1239-1246.
2. Choursaia M.K., Jain S.K., Pharmaceutical approaches to colon targeted drug delivery systems, J.Pharm. Phamaceut. Sci., 2003, 6(1), 33-66.
3. Friend D.R., New oral delivery systems for treatment of inflammatory bowel disease, Advanced Drug Delivery Reviews, 2005, 57(2), 247-265. (Pubitemid 39536101)
4. Mastiholimath V.S., Dandagi P.M., Jain S.S., Gadad A.P., Kulkarni A.R., Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma, Int. J. Pharm., 2007, 328, 49-56.
5. Chourasia M.K., Jain S.K., Pharmaceutical approaches to colon targeted drug delivery systems, J.Pharm. Pharmaceut. Sci., 2003, 6(1), 33-66.
6. Tomuţǎ I., Leucuţa S.E., Colonic delivery minitablets preparation and optimization using experimental design, Farmacia, 2005, LIII( 6), 80-88.
7. Şoica Codruţa, Vari C., Imre S., Gyéresi Á., Dehelean C., Dogaru M.. HPLC analysis of furosemide in rat plasma. Bioavailability study. Note 2, Farmacia, 2008, 56(5), 513-524.
8. Taerel A.E., Stiolicǎ Turcu A., Study on the range of drugs authorized in Romania - a determinant element for the accessibility and availability of drugs, Farmacia, 2009, 57(2), 254-259.
9. th Edition, CD version, 2007.
10. Takeuchi H., Yasuji T., Yamamoto H., Kawashima Y., Spray-dried lactose composite particles containing an ion complex of alginate-chitosan for designing a dry-coated tablet having a time-controlled releasing function, Pharma. Res., 2000, 17, 94-99.
11. Fukui E., Myamura N., Uemura K., Kobayashi M., Preparaion of enteric coated timed-release press-coated tablets and evaluation of their function by in vitro and in vivo tests for colon targeting, Int. J. Pharm., 2000, 204, 7-15.
12. Braha S., Gafitanu C., Braha E., Tuchilus C., Vasilescu M., Poiata A., Enhancement of dissolution of rifampicine and in vitro / in vivo evaluation of drug release from collyrium. Farmacia, 2009, 57(2), 25-64.
13. Ahjel D.W., Lupuleasa D., Enhancement of solubility and dissolution rate of different forms of atrovastatine calcium in direct compression tablet formulas. Farmacia, 2009, 57(3), 290-300.
14. Krishnaiah Y.S.R., Satyanarayana S., Rama Prasad Y.V., In vivo evaluation of 99mtc-DTPA and 99mtc-sulphur colloid as tracers in colonic drug delivery systems using gamma scintigraphy in volunteers., J Pharm Pharmaceut Sci, 2002, 5(1), 24-28.
15. Basit A.W., Podczeck F., Newton M.J., Waddington W.A., Ell P.J., Lacey L.F., The use of formulation technology to assess regional gastrointestinal drug absorption in human., Eur. J. Pharm. Sci., 2004, 21 (2), 179-189.